Category: Uncategorized

KUALA LUMPUR, March 7 — NEP Group, the leading media technology partner for content creators around the globe, has announced opening a new office in the United Arab Emirates (UAE) to meet the growing demand for its services, strengthening the company’s investment and presence in the Middle East.

Located across from the famed Khalifa Park in Abu Dhabi, NEP Middle East FZ LLC (NEP Middle East) will provide a wide range of outside broadcast solutions, including both on-site and remote production services, to enable clients to bring live sports and entertainment to fans and audiences around the region and worldwide.

NEP is expanding on its already extensive experience and work, ranging from covering UAE National Day celebrations and New Year’s Eve concerts, to many sporting events including Indian Premier League (IPL) 2021 and 2022, the International Cricket Council (ICC) Men’s T20 World Cup and T10 Cricket, and Ultimate Fighting Championship (UFC) Fight Island.

In addition, NEP’s Creative Technology business provides a full set of live event audio visual solutions to clients throughout the MENA region.

According to a statement, Saeed Izadi, current head of NEP’s Singapore and India businesses, has been appointed President of NEP Middle East, overseeing business strategy and operations for all three business units.

NEP also announced that Ammar Hina has joined the company as Business Development Director for the MENA region.

Hina brings more than 16 years of industry experience to lead business development and operations NEP Middle East, serving as the key contact for clients, major events and cross-divisional initiatives.

“I couldn’t be happier to welcome Ammar to NEP to spearhead our efforts for this very important market,” said Izadi.

“His expertise is enabling us to build a strong team locally while delivering superior service and innovative solutions for our clients located in the Middle East as well as international clients looking to share the events taking place in this great region with the rest of the world.”

Headquartered in the United States, NEP has operations in 25 countries with over 4,000+ employees.

— BERNAMA

KUALA LUMPUR, March 2 (Bernama) — Authorities in South China’s Hainan Province recently revealed the mascots for the 2022 China International Consumer Products Expo, styled after the Hainan gibbon.

Hainan gibbons are the most endangered of all gibbons and the world’s rarest primate. They are endemic to the southern Chinese island of Hainan.

The mascots reflect the green consumption approach of the expo, according to Ruslan Tulenov, a global media officer at the Hainan Provincial Bureau of International Economic Development.

The mascots embody the three dominant and distinctive industries of Hainan, namely the seed industry, deep-sea industry and aerospace industry, according to a statement.

Designers have endowed the mascots with diverse personalities, expecting that global enterprises and consumers can share opportunities and create a better life together through the expo, said Tulenov.

Themed ‘Share open opportunities, co-create a better life’, the event is scheduled to run from April 12 to 16 in Haikou, the capital of Hainan. This year, France will be the guest-of-honour country.

The exhibition area will span over 100,000 square metres, 80 per cent of which will be set up for overseas exhibitors featuring fashion, jewellery, food, medicine and other professional services.

The expo is expected to become a leading platform for global consumer fashion, and well-known brands will release their latest products during the exhibition.

— BERNAMA

KUALA LUMPUR, March 2 (Bernama) — George Clinical has announced the expansion of its renal scientific leadership into Latin America with the addition of subject matter expert Hernán Trimarchi, MD, PHD, FACP, FASN.

His research focuses on glomerular diseases, particularly proteinuria and podocyturia, IgA nephropathy, focal segmental glomerulosclerosis, and Fabry disease.

Dr Trimarchi, who is Head of the Division of Nephrology and Renal Transplantation at the Hospital Británico de Buenos Aires and a member of the steering committee of the International IgA Nephropathy Network, is involved in many clinical research studies related to glomerular diseases and chronic kidney diseases as member of the advisory board and steering committee, as key opinion leader (KOL) or national coordinator.

“We are very pleased to have Hernán join a global scientific leadership team so rich in kidney research expertise,” said Chief Medical Officer Dr Maria Ali in a statement.

“He joins an organisation with deep roots in Asia-Pacific and his presence in Latin America rounds out the expertise of our team demonstrating the global relationships of our scientific leaders and highlighting how we work with regional experts to ensure clinical trials are designed pragmatically.”

In addition to his scientific leadership duties for George Clinical, Dr Trimarchi is Professor of Medicine of the Universidad Católica Argentina and former Director of the Post Graduate Course of Internal Medicine of the Universidad de Buenos Aires School of Medicine at the Hospital Británico.

He is a member of the ISN Continuing Medical Education Program Committee and an active member of the International Society of Nephrology and of the International Society of Transplantation.

“Joining the scientific leadership of George Clinical offers me the chance to engage with a variety of renal studies that could deliver tangible value for those suffering from kidney disease not just in South America but worldwide,” said Dr Trimarchi.

With more than 20 years of experience and 400 people managing 38 geographical locations throughout the USA, Asia-Pacific region, and Europe, George Clinical provides the full range of clinical trial services to biopharmaceutical, medical device, and diagnostic customers, for all trial phases, registration, and post-marketing trials.

— BERNAMA

“Eyhey (hey), Ma (you), Hamo (OK)”… Drawing attention with additive rhythm beyond its sincerity

BUSAN, South Korea, Feb 25 (Bernama-BUSINESS WIRE) — The Busan Metropolitan City and Busan Tourism Organization (BTO) released a promotional video produced to introduce the unique vibe of Busan, an international tourism city, to the global market through Visit Busan YouTube channel on February 10.

This promotional video was planned as a unique content of Busan under the three themes of Sanbokdoro (Sanbok Road), Busan Eomuk (fish cake), and the vibe of Busan. The video shows the thrilling bus drive that can only be experienced on Sanbokdoro, Busan’s signature food, Eomuk and warm atmosphere in a traditional market, and the vibe of Busan spread in Sajik Baseball Stadium, the world’s largest Karaoke.

In particular, Eyheymahamo, a catchphrase similar to Abracadabra or Hakuna Matata that is repeated throughout the video, arouses the curiosity of overseas viewers. Eyheymahamo is a compound word of Eyhey, Ma, and Hamo, the dialect of Busan. This phrase means, “Hey, don’t worry. You’re okay.”

Mudd the Student, a rapper from Busan who competed at ‘Show Me the Money Season 10’ composed the song using the dialect of Busan and appeared on the video. The video also features choreography created by Hook, a dance crew from Street Woman Fighter. These artists will continue performing as the publicity models for Busan tourism.

Following the release of the video, the Busan Metropolitan City and BTO will start publicizing it from February 25 in the form of a short-form challenge together with famous global influencers using Tiktok, a global short video platform, and Weibo, a Chinese microblogging website.

With the video that shows the charm of Busan, an international tourism city, the Busan Metropolitan City will increase the global recognition of Busan as a city most loved by Koreans and a city overseas tourists would want to visit.

Visit the Visit Busan YouTube channel to watch the video: https://www.youtube.com/c/VISITBUSAN

Photos/Multimedia Gallery Available:
https://www.businesswire.com/news/home/52582830/en

Contact

Busan Tourism Organization
Strategic Planning Team
Mangil Cho, +82-51-780-2127
jomangil@bto.or.kr

Source : Busan Tourism Organization

http://mrem.bernama.com/viewsm.php?idm=42494

Global CDMO’s Heidelberg Facility Supplies more pDNA material to help address growing needs

Heidelberg, Germany, Feb 9 (Bernama-GLOBE NEWSWIRE) —AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced an expanded partnership to supply more plasmid DNA (pDNA) starting material for the Pfizer-BioNTech COVID-19 vaccine at the company’s Heidelberg facility.

According to a recent news release from Pfizer and BioNTech, the companies have started to develop an Omicron-based COVID-19 vaccine with first batches expected to be ready for delivery by end of March 2022.

“We are proud to continue to support BioNTech and supply them with pDNA materials for their vaccine production, as a part of the fight against new pandemic variants,” said AGC Biologics Chief Executive Officer, Patricio Massera. “Our pDNA services are a part of our growing global Cell and Gene Therapy offering that includes the development and manufacturing of cell therapies, viral vectors, and messenger RNA.”

“This type of work is what drives us every day,” says AGC Biologics General Manager, Heidelberg, Dieter Kramer. “We appreciate this opportunity to help make a difference in the lives of people around the world and produce life-saving treatments.”

The AGC Biologics Heidelberg facility has more than 20 years of experience delivering a wide range of programs for customers. The site is the company’s Center of Excellence for pDNA production, and a central part of the AGC Biologics global network of cell and gene therapy-focused facilities, with additional locations in Milan, Italy and Longmont, Colorado, USA.

For more information on AGC Biologics’ Plasmid DNA offering visit www.agcbio.com/plasmid-dna. To learn more about the company’s broader cell and gene therapy services visit www.agcbio.com/cell-therapy.

About AGC Biologics
AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with a strong commitment to delivering the highest standard of service as we work side-by-side with our clients and partners, every step of the way. We provide world-class development and manufacture of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cells. Our global network spans the U.S., Europe, and Asia, with cGMP-compliant facilities in Seattle, Washington; Boulder and Longmont, Colorado; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and Chiba, Japan and we currently employ more than 2,000 employees worldwide. Our commitment to continuous innovation fosters the technical creativity to solve our clients’ most complex challenges, including specialization in fast-track projects and rare diseases. AGC Biologics is the partner of choice. To learn more, visit www.agcbio.com.

Nick McDonald
AGC Biologics
(425) 419-3555
nmcdonald@agc.com

Source: AGC Biologics

–BERNAMA